Viatris VTRS
NASDAQ VTRS
$16.12 -0.13 (-0.77%)
As of: Aug 20, 2026 · 3:59 PM EDT

Viatris (VTRS) Gross Margin (2020 - 2026)

Viatris (VTRS) posted quarterly Gross Margin of 32.97% for Q1 2026, down 271.0% year-over-year from 19.28% in Q1 2025, and up 7.43% quarter-over-quarter from 30.69% in Q4 2025.

Viatris (VTRS) Gross Margin (2020 - 2026) Analysis & Trends

Viatris' Gross Margin history runs 7 years deep, the most recent figure standing at 32.97% for Q1 2026.

  • In Q1 2026, Gross Margin fell 271.0% year-over-year to 32.97%; the TTM figure through Mar 2026 stood at 34.36% (down 264.0% YoY), while the FY2025 annual figure was 35.06%, down 321.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 32.97%, up from 30.69% in the prior quarter.
  • The five-year high for Gross Margin was 42.99% in Q3 2023, with the low at 30.69% in Q4 2025.
  • The 5-year median for Gross Margin is 38.9% (2024), against an average of 38.42%.
  • The sharpest annual moves came in 2022 and 2024: Gross Margin surged 1677 bps in 2022, then slumped 713 bps in 2024.
  • Viatris' Gross Margin stood at 32.57% in 2022, then rose by 29 bps to 42.03% in 2023, then declined by 17 bps to 34.9% in 2024, then declined by 12 bps to 30.69% in 2025, then advanced by 7 bps to 32.97% in 2026.
  • Business Quant data shows VTRS's Gross Margin at 32.97% in Q1 2026, 30.69% in Q4 2025, and 36.48% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 51.98%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.30%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn 80.22%

Historic Data

Download Data
DateValue
Jun 30, 2026 38.77%
Mar 31, 2026 32.97%
Dec 31, 2025 30.69%
Sep 30, 2025 36.48%
Jun 30, 2025 37.35%
Mar 31, 2025 35.68%
Dec 31, 2024 34.90%
Sep 30, 2024 38.90%
Jun 30, 2024 38.18%
Mar 31, 2024 41.05%
Dec 31, 2023 42.03%
Sep 30, 2023 42.99%
Jun 30, 2023 41.05%
Mar 31, 2023 41.36%
Dec 31, 2022 32.57%
Sep 30, 2022 42.99%
Jun 30, 2022 41.49%
Mar 31, 2022 42.39%
Dec 31, 2021 35.11%
Sep 30, 2021 34.82%